Collaboration brings together clinical and claims-based quality intelligence with agentic AI to help healthcare organizations close care gaps and succeed in value-based care

协作将临床和基于索赔的质量智能与代理人工智能结合在一起，帮助医疗机构缩小护理差距并在价值导向的护理中取得成功。

COLUMBIA, Md.

哥伦比亚，马里兰州

,

，

March 10, 2026

2026年3月10日

/PRNewswire/ --

/PRNewswire/ --

Medisolv, Inc.

梅迪索尔夫公司

, a national leader in healthcare quality data management, today announced the acquisition of

，一家全国领先的医疗质量数据管理公司，今天宣布收购了

Lilac Software, Inc.

紫丁香软件公司

, an innovator in AI-driven predictive analytics and Medicare Advantage Stars performance. This acquisition represents a strategic expansion of Medisolv's capabilities into predictive, AI-powered quality intelligence designed to help healthcare organizations navigate increasingly complex value-based care models..

，一家在人工智能驱动的预测分析和医疗保险优势星级表现方面的创新者。此次收购代表了Medisolv战略能力的扩展，进入预测性、人工智能驱动的质量智能领域，旨在帮助医疗机构应对日益复杂的价值医疗模式。

For more than 25 years, Medisolv has helped hospitals, health systems, and accountable care organizations manage clinical quality measurement and regulatory reporting. Today, Medisolv supports more than 1,800 hospitals and some of the largest ACOs nationwide. This represents nearly one-quarter of U.S.

超过25年来，Medisolv一直帮助医院、卫生系统和责任医疗组织管理临床质量评估和监管报告。如今，Medisolv支持着1800多家医院和全国一些最大的ACO，这几乎代表了美国的四分之一。

hospitals and over 150 million patient records to power quality measurement and reporting. With the addition of Lilac, Medisolv expands its capabilities to include claims-based quality measurement, HEDIS performance analytics, and predictive insights that help organizations identify risk earlier and improve performance under value-based reimbursement models..

医院和超过1.5亿患者记录，以支持质量测量和报告。通过收购Lilac，Medisolv扩展了其能力，包括基于索赔的质量测量、HEDIS绩效分析以及帮助机构更早识别风险并改善在基于价值的报销模式下的表现的预测性洞察。

The acquisition also expands Medisolv's ability to support the next generation of value-based care requirements across both provider and payer organizations. Medisolv will incorporate Lilac's AI-enabled patient outreach technology into its existing solutions to support emerging patient engagement requirements, including use cases such as patient-reported outcome performance measures (PRO-PMs) and information transfer workflows, enabling healthcare organizations to collect critical quality data and engage patients at scale..

此次收购还扩大了Medisolv在提供方和支付方机构中支持下一代基于价值的护理需求的能力。Medisolv将把Lilac的AI驱动患者外展技术整合到其现有解决方案中，以满足新兴的患者参与需求，包括患者报告结果绩效指标（PRO-PM）和信息传递工作流程等用例，使医疗机构能够收集关键的质量数据，并大规模地与患者互动。

Beyond these CMS programs, the technology will help healthcare organizations identify and address gaps in care through scalable patient outreach and predictive analytics. Connecting provider clinical data with payer claims-based insights will give healthcare organizations a more complete view of quality performance while reducing the administrative burden of quality reporting..

除了这些CMS项目之外，该技术将通过可扩展的患者拓展和预测分析帮助医疗机构识别和解决护理中的缺口。将医疗服务提供者的临床数据与基于支付方索赔的洞察相结合，将使医疗机构能够更全面地了解质量表现，同时减轻质量报告的管理负担。

'This acquisition marks an important milestone in Medisolv's evolution,' said

“此次收购标志着Medisolv发展过程中的一个重要里程碑，”

David Lucey, Jr., CEO of Medisolv

大卫·卢塞，Medisolv首席执行官

. 'For decades, our mission has been to help healthcare organizations understand and improve their quality performance. With Lilac, we expand that mission from measurement to prediction to impact. By combining clinical quality data, claims analytics, and agentic AI, we are building a platform that not only reports on performance but actively helps providers and payers close gaps in care, reduce administrative burden, and succeed in value-based payment models.'.

“几十年来，我们的使命一直是帮助医疗机构理解和提升其质量表现。通过Lilac，我们将这一使命从衡量扩展到预测，再到产生影响。通过结合临床质量数据、索赔分析和智能代理AI，我们正在构建一个不仅报告表现，还积极帮助医疗服务提供者和支付方弥合护理差距、减轻行政负担，并在基于价值的支付模式中取得成功的平台。”

'We founded Lilac to help healthcare organizations turn data into action through AI,' said

“我们创立Lilac是为了帮助医疗机构通过人工智能将数据转化为行动，”

Neetu Rajpal, CEO and Co-Founder of Lilac

Neetu Rajpal，Lilac 的首席执行官兼联合创始人

. 'As payers and providers push toward value-based care, we're excited to bring our predictive analytics and AI capabilities together with Medisolv's trusted leadership in clinical quality management. By combining our claims-based insights with Medisolv's deep clinical expertise, we can accelerate the development of a new generation of agentic AI-driven solutions that help healthcare organizations not only measure performance but actively improve it.'.

“随着支付方和提供商推动基于价值的医疗，我们很高兴将我们的预测分析和人工智能能力与Medisolv在临床质量管理方面的可靠领导地位结合起来。通过将我们基于索赔的洞察与Medisolv深厚的临床专业知识相结合，我们可以加速开发新一代由人工智能驱动的解决方案，这些解决方案不仅帮助医疗机构评估绩效，还能积极改善绩效。”

About Lilac Software, Inc.

关于Lilac软件公司

Lilac Software is a leading provider of AI-powered data analytics for healthcare organizations. Our flagship Stars Management Platform delivers unprecedented visibility into every dimension of a health plan's Medicare Advantage Stars program. Our AI agents drive friendly and effective gap closure.

Lilac Software 是一家为医疗保健组织提供人工智能驱动的数据分析的领先供应商。我们的旗舰产品 Stars 管理平台为健康计划的 Medicare Advantage Stars 项目提供了前所未有的全方位可见性。我们的人工智能代理推动友好且高效的缺口闭合。

About Medisolv, Inc.

关于Medisolv公司

Medisolv is a national leader in healthcare quality data management, helping hospitals, health systems, providers, and ACOs deliver safer, higher-quality care. For more than 25 years, Medisolv has supported the full quality journey across inpatient, outpatient, and ACO programs through its all-in-one quality improvement solution, ENCOR, which supports more than 500 national quality and safety measures required by CMS, The Joint Commission, state agencies, and private payers.

Medisolv 是医疗保健质量数据管理的全国领导者，帮助医院、卫生系统、供应商和ACO提供更安全、更高质量的护理。25多年来，Medisolv通过其一站式质量改进解决方案ENCOR，支持住院、门诊和ACO项目的全方位质量管理，该方案支持CMS、联合委员会、州立机构和私人支付方要求的500多项国家质量和安全措施。

Medisolv's solutions span data abstraction, digital measures, registry reporting, performance analytics, and trusted advisory services. Trusted by more than 1,800 healthcare organizations and 100,000+ providers nationwide, Medisolv is recognized with Best in KLAS, Black Book, and HIMSS Policy Changemaker awards for excellence in client satisfaction and leadership in digital quality measurement.

Medisolv的解决方案涵盖数据抽象、数字测量、注册报告、绩效分析和可信的咨询服务。Medisolv受到全国1800多家医疗机构和超过10万名供应商的信任，因其在客户满意度和数字质量测量领域的卓越表现和领导力，荣获KLAS最佳奖、黑皮书奖以及HIMSS政策变革者奖。

For more information about Medisolv, please visit .

有关 Medisolv 的更多信息，请访问 。

www.medisolv.com

www.medisolv.com

.

。

SOURCE Medisolv

来源：Medisolv

21

21

%

%

more press release views with

更多新闻发布视图与

Request a Demo

请求演示